Skip to main content
. 2020 Oct 7;63(5):777–786. doi: 10.1007/s00234-020-02550-5

Table 2.

Outcome data and imaging variables

EVT [N = 41] Non-EVT [N = 10] Registry overall [N = 3180]
Functional independence (mRS 0–2) at 90 days, n(%; 95%CI) [known in] 21(54; 39–68) [N = 39] 1(10; 2–40) 1200(40; 39–42) [N = 2968]
Ordinal mRS at 90 days, median (IQR) [known in] 2(1–6) [N = 39] 5(4–6) 3(2–6) [N = 2968]
Successful reperfusion after EVT, n(%; 95%CI) [known in] 23(56; 41–70) NA 1913(62; 60–63) [N = 3096]
Mortality at 90 days, n(%; 95%CI) [known in] 10(26; 15–41) [N = 39] 3(30; 11–60) 863(29; 27–31) [N = 2968]
Delta-NIHSS at 24 h, median (IQR) [known in] 6(0–11) [N = 38] 4(3–9) [N = 8] 4(0–9) [N = 2838]
sICH, n(%; 95%CI) 2(5; 1–16) 1(10; 2–40) 188 (6; 5–7)
Patency of the infraclinoidal ICA, n(%; 95%CI) 5(12; 5–26) 8(80; 49–94) NA
Patency of the supraclinoidal ICA, n(%; 95%CI) 13(32; 20–47) 7(70; 40–89) NA
Patency of the PCOM, n(%; 95%CI) 14(34; 22–49) 6(60; 31–83) NA
Patency of the ACOM, n(%; 95%CI) 38(93; 81.97) 10(100; 72–100) NA
Patency of the ACOM and PCOM (complete circle of Willis), n(%; 95%CI) 26(63; 48–76) 4(40; 17–69) NA
Patency of the AChA, n(%; 95%CI) 18(44; 30–59) 3(30; 11–60) NA
Patency of the ophthalmic artery, n(%; 95%CI) 14(34; 22–49) 3(30; 11–60) NA
Plexus enhancement, n(%; 95%CI) 35(85; 72–93) 5(50; 24–76) NA
Hypodensity on NCCT*, n(%; 95%CI) 10(24; 14–39) 5(50; 24–76) NA
Hypodensity in internal capsule, n(%; 95%CI) 3(7; 3–19) 4(40; 17–69) NA
ASPECTS at baseline, median (IQR) [known in] 10(9–10) [N = 39] 9(8–10) [N = 9] NA
Collateral score, median (IQR) [known in] 3(2–3) [N = 37] 3(2.5–3) [N = 3] NA
CBV reduction on CTP, n(%; 95%CI) [known in] 5(50; 24–76) [N = 10] 5(71; 36–92) [N = 7] NA
CBF reduction on CTP, n(%; 95%CI) [known in] 6(60; 31–83) [N = 10] 7(100; 65–100) [N = 7] NA
CBF/CBV mismatch on CTP, n(%; 95%CI) [known in] 5(50; 24–76) [N = 10] 3(43; 16–75) [N = 7] NA

If the [known in] number is not shown, the variable was known in all patients. 95%CI in italics

AchA anterior choroidal artery, ACOM anterior communicating artery, CBF cerebral blood flow, CBV cerebral blood volume, CTP CT perfusion, Delta-NIHSS NIHSS at baseline minus NIHSS at 24 h after stroke, EVT endovascular treatment, ICA internal carotid artery, IQR interquartile range, IVT intravenous thrombolysis, M1 first segment of middle cerebral artery, min minutes, mRS modified Rankin Scale score, N number of patients, NA not applicable/available, NIHSS National Institute of Health Stroke Scale, sICH symptomatic intracranial hemorrhage

*Hypodensity on NCCT is defined as ASPECTS ≤ 9